Covid-19 pandemic, R&D, vaccines, and the urgent need of UBUNTU practice

Affiliations

¹ Senior Scientific Advisor, Immunobiological Technology Institute, Bio-Manguinhos/Fiocruz, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
² Carlos Chagas Filho Biophysics Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
³ Board of Director's Executive Advisor, Immunobiological Technology Institute, Bio-Manguinhos, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
⁴ Coordinator of the Center for Strategic Studies at Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil.
⁵ Collective Health Department, Federal University of Goiás, Goiânia, Goiás, Brazil.
⁶ Vice-President of Production and Innovation for Health, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
⁷ Respiratory Viruses Laboratory, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
⁸ Department of Preventive Medicine, Faculty of Medicine, Universidade de São Paulo, São Paulo, Brazil.
⁹ President of the Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
¹⁰ Coordination of Strategies for Regional and National Integration, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.

Akira Homma et al. Lancet Reg Health Am. 2021 Sep.

. 2021 Sep:1:100020.

doi: 10.1016/j.lana.2021.100020. Epub 2021 Jul 24.

¹ Senior Scientific Advisor, Immunobiological Technology Institute, Bio-Manguinhos/Fiocruz, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
² Carlos Chagas Filho Biophysics Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
³ Board of Director's Executive Advisor, Immunobiological Technology Institute, Bio-Manguinhos, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
⁴ Coordinator of the Center for Strategic Studies at Oswaldo Cruz Foundation, Rio de Janeiro, RJ, Brazil.
⁵ Collective Health Department, Federal University of Goiás, Goiânia, Goiás, Brazil.
⁶ Vice-President of Production and Innovation for Health, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
⁷ Respiratory Viruses Laboratory, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
⁸ Department of Preventive Medicine, Faculty of Medicine, Universidade de São Paulo, São Paulo, Brazil.
⁹ President of the Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
¹⁰ Coordination of Strategies for Regional and National Integration, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.

No abstract available

Keywords: Covid-19; Developing countries; Development challenges; Local production; Vaccine R&D; Vaccine manufacturing.

Conflict of interest statement

None

1. https://ourworldindata.org/covid-cases.
1. Raymundo CE, Oliveira MC, Eleuterio TA, André SR, da Silva MG, Queiroz ERDS, Medronho RA. Spatial analysis of COVID-19 incidence and the sociodemographic context in Brazil. PLoS One. 2021 Mar 1;16(3) doi: 10.1371/journal.pone.0247794. - DOI - PMC - PubMed
1. Domingues CMAS, Maranhão AGK, Teixeira AM, Fantinato FFS, Domingues RAS. The Brazilian National Immunization Program: 46 years of achievements and challenges. Cad Saúde Publica. 2020 Oct 26;(36Suppl 2) doi: 10.1590/0102-311x00222919. - DOI - PubMed
1. MacDonald N, Mohsni E, Al-Mazrou Y, Andrus JK, Arora N, Elden S, Madrid M-Y, Martin R, Mustafa AM, Rees H, Salisbury D, Zhao Q, Jones I, Steffen CA, Hombach J, O'Brien KL, Cravioto A. Global vaccine action plan lessons learned I: Recommendations for the next decade. Vaccine. 2020;38:5364–5371. doi: 10.1016/j.vaccine.2020.05.0033. - DOI - PMC - PubMed
1. Wouter OJ, Shadlen KCn Salcher-Konrad M, et al. Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment. Lancet. 2021 Mar 13;397(10278):1023–1034. doi: 10.1016/S0140-6736(21)00306-8. - DOI - PMC - PubMed